Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

By clicking “Accept” you acknowledge and agree that neither ITGR nor third party provider Virtua Research, Inc. (“Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the Linked Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against ITGR and Virtua and further acknowledge and agree that in no event shall ITGR or Virtua, its officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to this disclaimer or the External Site

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if ITGR and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

Non-GAAP Information

In addition to disclosing results determined in accordance with GAAP, ITGR may also disclose certain non-GAAP and pro forma non-GAAP results of operations, including certain ratios, operational and miscellaneous data, as well as net income, diluted earnings per share, operating expenses, and operating income that make certain adjustments or exclude certain charges and gains that are outlined in the schedules included in this website. Management believes that this non-GAAP and pro forma non-GAAP information provides investors with additional information to assess ITGR operating performance by making certain adjustments or excluding costs or gains and assists investors in comparing our operating performance to prior periods. Management uses this non-GAAP and pro forma non-GAAP information, along with GAAP information, in evaluating its historical operating performance. ITGR and Virtua also take no responsibility for third party pricing data provided for informational purposes and certain ratio results formulated from the provided third party pricing data.

The non-GAAP information is not prepared in accordance with GAAP and may not be comparable to non-GAAP information used by other companies. The non-GAAP information should not be viewed as a substitute for, or superior to, other data prepared in accordance with GAAP.

Integer to Exhibit at 2023 MD&M West Expo, February 7 – 9

February 2, 2023
~ Explore Capabilities That Enable Emerging Products at Booth #1759 ~

PLANO, Texas, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M West Exposition at the Anaheim Convention Center in Anaheim, Calif., from Feb. 7 – 9, 2023.

Attendees are invited to visit Integer at booth #1759 to learn more about Integer’s range of innovative end-to-end medical device design, development and manufacturing solutions. This encompasses expanded offerings as a result of the acquisitions of Aran Biomedical in April 2022, and Oscor in December 2021. Integer solutions include components, sub-assemblies, manufacturing transfers, custom development and finished devices.

During the event, the Integer team will be on hand to discuss how we blend our technology, expertise and resources to provide solutions that amplify our customers’ innovation, as well as specific capabilities and solutions including:

  • New Gen 2 CFx Battery Technology: The next generation of market-leading primary battery technology for active implantable devices supports miniaturization for substantial reduction in device size. It also meets high current pulsing demands to provide up to 50 percent improved runtimes for new advanced devices with Bluetooth communication.
  • Electrophysiology Solutions: Integer’s complete range of transseptal access, diagnostic and ablation device solutions include market-ready guiding sheaths, catheter shafts, complex distal assemblies and more. This includes designing and developing catheters and sub-assemblies in our R&D centers of excellence, vertically integrated manufacturing to support the entire bill of materials, and strategic manufacturing locations, including in low-cost countries.
  • Expanded Leads Capabilities: Our proven end-to-end design, development and scalable manufacturing solutions accelerate and optimize customers’ leads programs. This includes designing and developing full lead systems and sub-assemblies, vertically integrated manufacturing, as well as customizable services to complement customers’ existing capabilities.
  • Neurovascular Solutions: Integer’s full suite of neurovascular solutions include complex braided implants, guidewires, miniaturized wire-based delivery systems, large bore access and aspiration catheters and advanced balloon guide catheters. Differentiated capabilities such as ultrathin PTFE liners as well as automated micro coiling and grinding for complex device delivery enable our customers’ innovation. Our neurovascular product development team, which is driven by the guiding principles of quality, speed and partnership, will help you bring your breakthrough neurovascular device to market faster.
  • Structural Heart Capabilities: Integer’s strong track record in developing access and delivery products for structural heart accelerates new product development to help medical device companies compete in the fast-growing structural heart market. Our full range of structural heart solutions includes guidewires, steerable introducers and sheaths, therapy delivery systems involving large bore metal hypotubes with complex laser cut articulations, and embolic protection devices. Integer also offers a diverse range of capabilities for structural heart implants, enabling novel solutions for next-generation devices incorporating frames, custom textiles, PTFE, electrospun materials and elastomeric coatings for leading structural heart applications.

“In recent years, Integer has made a number of strategic investments to support growing global customer demand,” said Payman Khales, president of Integer’s Cardio and Vascular business. “Focusing on expanding our capabilities and furthering our global footprint have enabled us to bolster our solutions and R&D expertise in a number of areas, including in the structural heart, electrophysiology, neurovascular and neuromodulation markets. In addition, our focus on strategic expansions – including breaking ground on a new facility in Galway, Ireland, the recent opening of a new building in the Dominican Republic, and a sizeable expansion to our New Ross facility in Ireland – will allow us to continue increasing our capacity in the areas with the most global demand, such as catheters, delivery systems, stimulation leads and guidewires. We’re looking forward to discussing this and more at MD&M West.”

Learn more about Integer at www.integer.net.

About Integer ®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, the company develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include Greatbatch Medical®, Lake Region Medical® and Electrochem®. Additional information is available at www.integer.net.

Investor Relations:         Media Relations:
Tony Borowicz   Kelly Butler
tony.borowicz@integer.net   kelly.butler@integer.net
716.759.5809    214.618.4216

Primary Logo

Source: Integer Holdings Corporation